Y-box binding protein 1 augments sorafenib resistance via the PI3K/Akt signaling pathway in hepatocellular carcinoma

por Liu, Ting, Xie, Xiao-Li, Zhou, Xue, Chen, Sheng-Xiong, Wang, Yi-Jun, Shi, Lin-Ping, Chen, Shu-Jia, Wang, Yong-Juan, Wang, Shu-Ling, Zhang, Jiu-Na, Dou, Shi-Ying, Jiang, Xiao-Yu, Cui, Ruo-Lin, Jiang, Hui-Qing
Publicado 2021